Results 151 to 160 of about 18,607 (256)

New tools for diagnosis of primary immunodeficiencies: from awareness to artificial intelligence. [PDF]

Front Immunol
Soler-Palacín P, Rivière JG, Burns SO, Rider NL.   +3 more
europepmc   +1 more source

A British Pharmacological Society Position Statement on Medications in Pregnancy and Lactation

British Journal of Clinical Pharmacology, EarlyView.
Agnesa Mustafa, Cleodie C. Swire, Reya V. Shah, Bernadette Jenner, Rory H. McLean, Muhammad Shamsher Ahmed, Adrie Bekker, Julia Zöllner, Rachel K. Scott, Robert R. Bies, Sara K. Quinney, Dagan O. Lonsdale, Emma Forton Magavern, Catriona Waitt, Anita Banerjee   +14 more
wiley   +1 more source

Extended High‐Risk HPV Genotyping With BD Onclarity Enhances Anal Cancer Screening Among High‐Risk Populations: A Cross‐Sectional Study

Diagnostic Cytopathology, EarlyView.
ABSTRACT Background Anal cancer rates are rising among women, immunocompromised individuals, and Men who have sex with Men (MSM), independent of HIV status. While high‐resolution anoscopy remains the diagnostic standard, limited access has increased interest in alternative screening.
Daisy Maharjan, Joshua Waters, Melissa Randolph, Benjamin Shuler, Julie Borum, Sheila Segura   +5 more
wiley   +1 more source

13q Deletion Syndrome Presenting with Lymphopenia Detected Through Newborn Screening for Primary Immunodeficiencies. [PDF]

Int J Mol Sci
Efimova I, Mukhina A, Markova Z, Mordanov S, Soprunova I, Pershin D, Balinova N, Petrusenko Y, Meleshko D, Zinchenko R, Shilova N, Voronin S, Shcherbina A, Kutsev S, Marakhonov A.   +14 more
europepmc   +1 more source

Primary Immunodeficiencies and Hematologic Malignancies: A Diagnostic Approach. [PDF]

Front Immunol, 2022
Chandra S, Kalashnikova T, Wright NAM, Dávila Saldaña BJ.   +3 more
europepmc   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

From Selective Immunoglobulin E (IgE) Deficiency to Primary Immunodeficiencies Coexisting with Chronic Spontaneous Urticaria: A Call for Immunological Survey. [PDF]

J Clin Pract Res
Türk M, Yılmaz İ.
europepmc   +1 more source

Creating Awareness for Primary Immunodeficiencies in Japan. [PDF]

Front Immunol, 2021
Takada H.
europepmc   +1 more source

Decreased IL-17-producing T_H cells as a diagnostic marker for STAT signaling-related primary immunodeficiencies. [PDF]

J Allergy Clin Immunol Glob
Molnár E, Kovács G, Tahami F, Andrikovics H, Burns S, Grigoriadou S, Buckland M, Gilmour K.   +7 more
europepmc   +1 more source

Mid-Regional Proadrenomedullin Levels in Primary Immunodeficiencies Complicated with Pulmonary Manifestations. [PDF]

Indian J Clin Biochem, 2023
Azarsiz E, Karaca N, Kutukculer N.
europepmc   +1 more source